ISSN 1214-0287 (on-line)
ISSN 1214-021X (printed)

Volume 5 (2007), No 1, p 31-38

Protective role of tetrahydrocurcumin on changes in the fatty acid composition in streptozotocin - nicotinamide induced type 2 diabetic rats

Pidaran Murugan, Leelavinothan Pari

Address: Leelavinothan Pari, Department of Biochemistry, Annamalai University, Annamalai Nagar-608 002, Tamil Nadu, India

Received 28th August 2006.
Published online 12th January 2007.

Full text article (pdf)
Full text article (html)

Curcumin is the most active component of turmeric. It is believed that curcumin is a potent antioxidant and anti-inflammatory agent. Tetrahydrocurcumin (THC), one of the major metabolites of curcumin, exhibits many of the same physiological and pharmacological activities as curcumin and in some systems may exert greater antioxidant activity than curcumin. The aim of this study was to evaluate the effect of THC on the blood glucose, plasma insulin and fatty acid composition of the total lipids in the liver, kidney and brain of control and streptozotocin (STZ)-nicotinamide diabetic rats. The analysis of fatty acids showed that there was a significant increase in the concentrations of palmitic acid (16:1), stearic acid (18:0) and oleic acid (18:1) in the liver, kidney and brain, whereas the concentrations of linolenic acid (18:3) and arachidonic acid (20:4) were significantly decreased. Oral administration of the THC (80 mg/kg body weight) for 45 days to diabetic rats decreased the concentrations of fatty acids, viz., palmitic, stearic, and oleic acid, whereas linolenic and arachidonic acid were elevated. These results suggest that THC exhibits antidiabetic and antihyperlipidemic effects in STZ-nicotinamide induced diabetic rats. It also prevents the fatty acid changes produced during diabetes. The antidiabetic and antihyperlipidaemic effects of THC are more potent than those of curcumin at the same dose. The results of the present study indicate that THC showed an antihyperlipidemic effect in addition to its antidiabetic effect in type 2 diabetic rats.

diabetes; tetrahydrocurcumin; curcumin; blood glucose; insulin; fatty acids

Aggarwal B, Kumar A, Bharti A: Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23:363-398, 2003.

Anusuya S, Menon VP: Protection of pancreatic beta- cell by the potential antioxidant bis-Ohydroxycinnamoyl methane, analogue of natural curcuminoid in experimental diabetes. J Pharm Pharm Sci 6:327-333, 2003.

Arun N, Nalini N: Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum Nutr 57:41-51, 2002.

Babu P, Srinivasan K: Hypolipidemic action of curcumin, the active principle of turmeric Curcuma longa in streptozotocin induced diabetic rats. Mol Cell Biochem 166:169-175, 1997.

Babu P, Srinivasan K: Amelioration of renal lesions associated with diabetes by dietary curcumin in streptozotocin diabetic rats. Mol Cell Biochem 181:87-96, 1998.

Bassirat M, Khalil Z: Endothelin and free radicals modulate microvascular responses in streptozotocin diabetic rats. Microvasc Res 59:88-98, 2000.

Baynes YW, Thorpe R: Role of oxidative stress in diabetic complications. Diabetes 48:1-9, 1999.

Bopanna KN, Kannan J, Sushma G, Balaraman R, Rathod SP: Antidiabetic and antihyperlipidemic effect of neem seed kernal powder on alloxan diabetes. Indian J Pharmacol 59:8-13, 1997.

Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2001.

Cameron NE, Cottter MA: Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res Clin Pract 45:137-146, 1997.

Demaison L, Sergiel JP, Moreau D, Grynberg A: Influence of the phospholipid n-6/n-3 polyunsaturated fatty acid ratio on the mitochodrial oxidative metabolism before and after myocardial ischemia. Biochim Biophys Acta 1227:53-59, 1994.

Duncan BD: Multiple ranges tests for correlated and heteroscedastic means. Biometrics 13:359-364, 1957.

Faas FH, Dang AQ, Norman J, Carter WJ: Red blood cell and plasma fatty acid composition in diabetes mellitus. Metab Clin Exp 37:711-713, 1988.

Farva D, Goji LA, Joseph PK, Augusti KT: Effects of garlic oil on streptozotocin-diabetic rats maintained on normal and high fat diets. Indian J Biochem Biophys 23:24-27, 1986.

Folsom AR, Ma J, Mc Govern PG, Eckfeldt H: Relation between phospholipids, saturated fatty acids and hyperinsulinemia. Metab Clin Exp 45:223-228, 1996.

Halim Eshrat M, Hussain A: Hypoglycemic, hypolipidemic and antioxidant properties of combination of curcumin from Curcuma longa, Linn. and partially purified product from Abroma augusta, Linn. in streptozotocin induced diabetes. Indian Clin Biochem 17:33-43, 2002.

Holder GM, Plummer JL, Ryan AJ: The metabolism and excretion of curcumin (1,7- Bis(4-hydroxy-3-methoxyphenyl)-1,6-hepadiene- 3,5-dione) in rat. Xenobiotica 8:761-768, 1978.

Ireson CR: Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 11:105-111, 2002.

Khopde SM, Priyadarisini KI, Guha SN, Satav JG, Venkatesan P, Rao MN: Inhibition of radiation-induced lipid peroxidation by tetrahydrocurcumin: Possible mechanism by pulse radiolysis. Biosci Biotechnol Biochem 64:503-509, 2000.

King H, Aubert R, Herman WH: Global burden of diabetes 1995-2025. Diabetes Care 21:414-143, 1998.

Lin JK, Lin-Shiau SY: Mechanisms of cancer chemoprevention by curcumin. Proc Natl Sci Counc Repub China B 25:59-66, 2001.

Mahesh T, Balasubashini M, Menon V: Effect of photo-irradiated curcumin treatment against oxidative stress in streptozotocin-induced diabetic rats. J Med Food 8:251-255, 2005.

Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, Novelli M, Ribes G: Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47:224-229, 1998.

Morrison WR, Smith LM: Preparations of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride methanol. J Lipid Res 5:600-607, 1964.

Naito M, Wu X, Normura H, Kodama M, Kato Y, Osaswa T: The protective effect of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits. J Atheroscler Thromb 9:243-250, 2002.

Nishiyama T, Mae T, Kishida H, Tsukagawa M, Mimaki Y, Kuroda M, Sashida Y, Takahashi K, Kawada T, Nakagawa K, Kitahara M: Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L) suppress and increase in blood glucose level in type 2 diabetic KK-Ay mice. J Agric Food Chem 53:959-963, 2005.

Okada K, Wangpoengtrakul C, Tanaka T, Toyokuni S, Uchida K, Osawa T: Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. J Nutr 31:2090-2095, 2001.

Pari L, Murugan P: Protective role of tetrahydrocurcumin against erythromycin estolate induced hepatotoxicity. Pharmacol Res 49:481-486, 2004.

Pari L, Murugan P: Effect of tetrahydrocurcumin on blood glucose, plasma insulin and hepatic key enzymes in streptozotocin induced diabetic rats. J Basic Clin Physiol Pharmacol 16:257-274, 2005.

Pelikanova T, Kohout M, Valek J, Base J, Stefka Z: Fatty acid composition of serum lipids and erythrocyte membranes in type 2 (non-insulindependent) diabetic men. Metabolism 40:175-180, 1991.

Pushparaj P, Tan CH, Tan BKH: Effects of Averrhoa bilimbi leaf extract on blood glucose and lipids in streptozotocin diabetic rats. J Ethnopharmacol 72:69-76, 2000.

Ravi P, Dai S, Tam KC: Synthesis and selfassembly of [6O]fullerene containing sulfobetaine polymer in aqueous solution. J Phys Chem B Condens Matter Mater Surf Interfaces Biophys 8:22791-22798, 2005.

Robertson RP: Chronic oxidative stress: a central mechanism for glucose toxicity in pancreatic islet beta cell in diabetes. J Biol Chem 279:42351-42354, 2004.

Sajithlal G, Chithra P, Chandrakasan G: Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. Biochem Pharmacol 56:1607-1614, 1998.

Seigneur M, Freyburger G, Gin H, Claverie M, Lardeau D, Lacape G: Serum fatty acid profiles in type I and II diabetes; metabolic alteration of fatty acids of the main serumlipids. Diabetes Res Clin Pract 23:169-177, 1994.

Sidhu G, Mani H, Gaddipati J, Singh A, Seth P, Banaudha K, Patnaik G, Maheshwari R: Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair Regen 7:362-374, 1999.

Stubbs CD, Smith AD: The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta 779:89-137, 1984.

Sugiyama Y, Kawakishi S, Osawa T: Involvement of the beta-diketone moiety in the antioxidant mechanism of tetrahydrocurcuminoids. Biochem Pharmacol 52:519-525, 1996.

Suryanarayana P, Saraswat M, Mrudula T, Krishna P, Krishnaswamy K, Reddy G: Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest Ophthalmol Vis Sci 46:2092-2099, 2005.

Tilvis RS, Helve E, Miettinen TA: Improvement of diabetic control by continuous subcutaneous insulin infusion therapy changes fatty acid composition of serum lipids and erythrocytes in type 1 diabetes. Diabetologia 29:690-694, 1986.

Vessby B: Dietary fat and insulin actions in humans. Br J Nutr 83:91-96, 2000.

Warier PK: Eugenia jambolana Linn. In Warier PK, Nambiar VPK, Ramankutty C (eds): Indian Medicinal Plants, Orient Longman, Madras 1995, pp. 45-51.

Yang Q, Yan D, Wang Y: K+ regulates DNA binding of transcription factors to control gene expression related to neuronal apoptosis. Neuroreport 17:1199-1204, 2006.

Hasan AA, Madkor H, Wageh S. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system. Drug Delivery. 20: 120-126, 2013.

Devarshi PP, Jangale NM, Ghule AE, Bodhankar SL, Harsulkar AM. Beneficial effects of flaxseed oil and fish oil diet are through modulation of different hepatic genes involved in lipid metabolism in streptozotocin-nicotinamide induced diabetic rats. Genes Nutr. 8: 329-342, 2013.

Naresh KR, Sundaram R, Shanthi P, Sachdanandam P. Protective role of 20-OH ecdysone on lipid profile and tissue fatty acid changes in streptozotocin induced diabetic rats. Eur J Pharmacol. 698: 489-498, 2013.

Saravanan G, Ponmurugan P. Ameliorative potential of S-allylcysteine: Effect on lipid profile and changes in tissue fatty acid composition in experimental diabetes. Exp Toxicol Pathol. 64: 639-644, 2012.

Sridevi M, Kalaiarasi P, Pugalendi KV. Antihyperlipidemic activity of alcoholic leaf extract of Solanum surattense in streptozotocin-diabetic rats. Asia-Pac J Tropic Biomed. 1(Suppl. 2): S276-S280, 2011.

Kumar G, Banu S, Murugesan AG. Influence of Helicteres isora administration for diabetes mellitus: The effect on changes in tissue fatty acid composition. Food Chem Toxicol. 47: 1826-1830, 2009.

Ghosh SS, Massey HD, Krieg R, Fazelbhoy ZA, Ghosh S, Sica DA, Fakhry I, Gehr TWB. Curcumin ameliorates renal failure in 5/6 nephrectomized rats: Role of inflammation. Am J Physiol - Renal Physiol. 296: F1146-F1157, 2009.

Murugan P, Pari L, Rao CA. Effect of tetrahydrocurcumin on insulin receptor status in type 2 diabetic rats: studies on insulin binding to erythrocytes. J Biosciences. 33: 63-72, 2008.